News Link
Lee Ye-hwa, CEO of Vuno, Kim Dong-min, CEO of JLK, and Kwak Min-chul, CEO of Selvas AI and Mediana are taking a commemorative photo at the Medical AI Alliance agreement ceremony held at the JLK headquarters in Gangnam-gu, Seoul on the 7th. JLK
Four domestic medical artificial intelligence (AI) companies have formed the Medical AI Alliance (MASA) to speed up joint research and commercialization of related technologies. The four companies, JLK, Selvas AI, Mediana, and Bruno, have decided to cooperate in overseas expansion while establishing a joint domestic sales network.
JLK announced on the 8th that it held a launching ceremony for the Medical AI Alliance with Selvas AI, Mediana, and Vuno at JLK Tower in Gangnam-gu, Seoul on the 7th and signed a strategic business agreement (MOU) for joint research and commercialization of AI medical technology. The signing ceremony was attended by major executives of four companies, including CEO Kim Dong-min of JLK, CEO Lee Ye-ha, CEO of Bruno, and CEO Kwak Min-chul of Selvas AI and Mediana.
With this agreement, the four companies will jointly conduct joint research and commercialization of AI medical technology, discover new service and business models, secure actual use data based on cooperative hospitals, advance AI medical models, expand overseas and cooperate with global medical institutions, and jointly promote integrated sales and marketing using AI medical solutions.
Medical AI Alliance will maintain a close cooperative relationship over the next three years and expand the scope of R&D and business cooperation in stages. It is also considering expanding its alliance by seeking additional partnerships.
News Link
Lee Ye-hwa, CEO of Vuno, Kim Dong-min, CEO of JLK, and Kwak Min-chul, CEO of Selvas AI and Mediana are taking a commemorative photo at the Medical AI Alliance agreement ceremony held at the JLK headquarters in Gangnam-gu, Seoul on the 7th. JLK
Four domestic medical artificial intelligence (AI) companies have formed the Medical AI Alliance (MASA) to speed up joint research and commercialization of related technologies. The four companies, JLK, Selvas AI, Mediana, and Bruno, have decided to cooperate in overseas expansion while establishing a joint domestic sales network.
JLK announced on the 8th that it held a launching ceremony for the Medical AI Alliance with Selvas AI, Mediana, and Vuno at JLK Tower in Gangnam-gu, Seoul on the 7th and signed a strategic business agreement (MOU) for joint research and commercialization of AI medical technology. The signing ceremony was attended by major executives of four companies, including CEO Kim Dong-min of JLK, CEO Lee Ye-ha, CEO of Bruno, and CEO Kwak Min-chul of Selvas AI and Mediana.
With this agreement, the four companies will jointly conduct joint research and commercialization of AI medical technology, discover new service and business models, secure actual use data based on cooperative hospitals, advance AI medical models, expand overseas and cooperate with global medical institutions, and jointly promote integrated sales and marketing using AI medical solutions.
Medical AI Alliance will maintain a close cooperative relationship over the next three years and expand the scope of R&D and business cooperation in stages. It is also considering expanding its alliance by seeking additional partnerships.